Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,011 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase III, randomized, open-label study of daily imatinib mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: tyrosine kinase inhibitor optimization and selectivity study.
Cortes JE, Baccarani M, Guilhot F, Druker BJ, Branford S, Kim DW, Pane F, Pasquini R, Goldberg SL, Kalaycio M, Moiraghi B, Rowe JM, Tothova E, De Souza C, Rudoltz M, Yu R, Krahnke T, Kantarjian HM, Radich JP, Hughes TP. Cortes JE, et al. Among authors: yu r. J Clin Oncol. 2010 Jan 20;28(3):424-30. doi: 10.1200/JCO.2009.25.3724. Epub 2009 Dec 14. J Clin Oncol. 2010. PMID: 20008622 Free PMC article. Clinical Trial.
Nilotinib vs imatinib in patients with newly diagnosed Philadelphia chromosome-positive chronic myeloid leukemia in chronic phase: ENESTnd 3-year follow-up.
Larson RA, Hochhaus A, Hughes TP, Clark RE, Etienne G, Kim DW, Flinn IW, Kurokawa M, Moiraghi B, Yu R, Blakesley RE, Gallagher NJ, Saglio G, Kantarjian HM. Larson RA, et al. Among authors: yu r. Leukemia. 2012 Oct;26(10):2197-203. doi: 10.1038/leu.2012.134. Epub 2012 May 18. Leukemia. 2012. PMID: 22699418 Clinical Trial.
ASCEND-8: A Randomized Phase 1 Study of Ceritinib, 450 mg or 600 mg, Taken with a Low-Fat Meal versus 750 mg in Fasted State in Patients with Anaplastic Lymphoma Kinase (ALK)-Rearranged Metastatic Non-Small Cell Lung Cancer (NSCLC).
Cho BC, Kim DW, Bearz A, Laurie SA, McKeage M, Borra G, Park K, Kim SW, Ghosn M, Ardizzoni A, Maiello E, Greystoke A, Yu R, Osborne K, Gu W, Scott JW, Passos VQ, Lau YY, Wrona A. Cho BC, et al. Among authors: yu r. J Thorac Oncol. 2017 Sep;12(9):1357-1367. doi: 10.1016/j.jtho.2017.07.005. Epub 2017 Jul 17. J Thorac Oncol. 2017. PMID: 28729021 Free article. Clinical Trial.
Intelligent in-cell electrophysiology: Reconstructing intracellular action potentials using a physics-informed deep learning model trained on nanoelectrode array recordings.
Rahmani K, Yang Y, Foster EP, Tsai CT, Meganathan DP, Alvarez DD, Gupta A, Cui B, Santoro F, Bloodgood BL, Yu R, Forro C, Jahed Z. Rahmani K, et al. Among authors: yu r. Nat Commun. 2025 Jan 14;16(1):657. doi: 10.1038/s41467-024-55571-6. Nat Commun. 2025. PMID: 39809732 Free article.
Enhancing the Travel Experience for People with Visual Impairments through Multimodal Interaction: NaviGPT, A Real-Time AI-Driven Mobile Navigation System.
Zhang H, Falletta NJ, Xie J, Yu R, Lee S, Billah SM, Carroll JM. Zhang H, et al. Among authors: yu r. GROUP ACM SIGCHI Int Conf Support Group Work. 2025;2025(Companion):29-35. doi: 10.1145/3688828.3699636. Epub 2025 Jan 12. GROUP ACM SIGCHI Int Conf Support Group Work. 2025. PMID: 39807354 Free PMC article.
Comparison of Jinzhen oral liquid and ambroxol hydrochloride and clenbuterol hydrochloride oral solution in the treatment of acute bronchitis in children: A multicenter, non-inferiority, prospective, randomized controlled trial.
Fan Q, Wu C, Du Y, Wang B, Xie Y, Zhang Z, Su W, Wang Z, Xu C, Li X, Ding Y, An X, Chen J, Xiao Y, Yu R, Li N, Wang J, Teng Y, Lv H, Yang N, Wen Y, Huang X, Pan W, Liu Y, Xi X, Zhao Q, Liu C, Xu J, Zhang H, Zhuo L, Rong Q, Xia Y, Shen Q, Li S, Wang J, Wu S. Fan Q, et al. Among authors: yu r. Acta Pharm Sin B. 2024 Dec;14(12):5186-5200. doi: 10.1016/j.apsb.2024.09.001. Epub 2024 Sep 3. Acta Pharm Sin B. 2024. PMID: 39807315 Free PMC article. Clinical Trial.
8,011 results